BVL
MRNA icon

Beau Ventures, LLc’s Moderna MRNA Stock Holding History

Beau Ventures, LLc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$193M Sell
1,000,056
-106
-0% -$11.4K 18.17% 2
2026
Q2 		$70M Hold
1,000,162
– – 7.63% 3
2026
Q1 		$50.8M Buy
1,000,162
+56
+0% +$2.61K 6.81% 3
2025
Q4 		$29.5M Buy
+1,000,106
New +$27.2M 3.67% 5

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
PFM
Patton Fund Management Dallas, Texas $389M AUM 65.14% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $187M AUM 21.63% 1-Year Est. Return
NIM
Nicollet Investment Management Minneapolis, Minnesota $336M AUM 22.24% 1-Year Est. Return
BSCCG
Blue Sky Capital Consultants Group Poway, California $239M AUM 14.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Beau Ventures, LLc's MRNA Position: Q3 2026 in Review

Beau Ventures, LLc reduced its Moderna (MRNA) stake by 0.01% in Q3 2026, selling an estimated $11.4K and leaving 1,000,056 shares worth $193M. The position accounts for 18.17% of the portfolio, ranked #2.

Beau Ventures, LLc first reported a position in MRNA in Q4 2025 and has held it in 4 quarters since. 69 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Beau Ventures, LLc held 1,000,056 shares of Moderna worth $193M as of Q3 2026.
  • Beau Ventures, LLc sold 106 Moderna shares in Q3 2026, an estimated $11.4K.
  • Moderna made up 18.17% of Beau Ventures, LLc's portfolio in Q3 2026, its #2 holding.
  • Beau Ventures, LLc first reported a position in Moderna in Q4 2025 and has held it in 4 quarters since.
  • 69 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Beau Ventures, LLc's 13F filing for Q3 2026, filed 14 Oct 2026.